Kaplan-Meier analysis revealed that GBM patients with high ZHX1 expression (30% upper percentile, n = 45) survived longer than the patients with low ZHX1 expression (30% lower percentile, n = 45) (Figure 1D; p = 0.0409). Here, ZHX1 is linked to glioblastoma.